Iron toxicity and antioxidant nutrients

Toxicology

Volumn 180, Issue 1, 2002, Pages 23-32

  Fraga, Cesar G ^a   Oteiza, Patricia I ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Flavonoids; Free radicals; Oxidation; Vitamin; Zinc

Indexed keywords

ANTIOXIDANT; FREE RADICAL; IRON; METAL;

ARTICLE; CHEMICAL INTERACTION; DEVELOPMENT; DISEASE COURSE; DNA DAMAGE; FOOD INTAKE; GROWTH; HUMAN; IMMUNOPATHOLOGY; IRON OVERLOAD; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SURVIVAL; TISSUE INJURY; TISSUE LEVEL;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; FLAVONOIDS; HUMANS; IRON; IRON CHELATING AGENTS; IRON OVERLOAD; LEAD POISONING; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; VITAMIN E; ZINC;

EID: 0037201941     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(02)00379-7     Document Type: Article

References (75)

1. Bartfay W.J., Bartfay E. Selenium and glutathione peroxidase with beta-thalassemia major. Nurs. Res. 50:2001;178-183.
2. Bartfay W.J., Hou D., Brittenham G.M., Bartfay E., Sole M.J., Lehotay D., Liu P.P. The synergistic effects of vitamin E and selenium in iron-overloaded mouse hearts. Can. J. Cardiol. 14:1998;937-941.
3. Beckman L.E., Van Landeghem G.F., Sikstrom C., Wahlin A., Markevarn B., Hallmans G., Lenner P., Athlin L., Stenling R., Beckman L. Interaction between haemochromatosis and transferrin receptor genes in different neoplastic disorders. Carcinogenesis. 20:1999;1231-1233.
4. Berg D., Gerlach M., Youdim M.B., Double K.L., Zecca L., Riederer P., Becker G. Brain iron pathways and their relevance to Parkinson's disease. J. Neurochem. 79:2001;225-236.
5. Buettner G.R., Jurkiewicz B.A. Catalytic metals, ascorbate and free radicals: combinations to avoid. Radiat. Res. 145:1996;532-541.
6. Carr A., Frei B. Does vitamin C act as a pro-oxidant under physiological conditions. FASEB J. 13:1999;1007-1024.
7. Chen K., Suh J., Carr A.C., Morrow J.D., Zeind J., Frei B. Vitamin C suppresses oxidative lipid damage in vivo, even in the presence of iron overload. Am. J. Physiol. Endocrinol. Metab. 279:2000;E1406-E1412.
8. Christensen M.J., Olsen C.A., Hansen D.V., Ballif B.C. Selenium regulates expression in rat liver of genes for proteins involved in iron metabolism. Biol. Trace Elem. Res. 74:2000;55-70.
9. Cohen N.L., Keen C.L., Lonnerdal B., Hurley L.S. The effect of copper chelating drugs on liver iron mobilisation in the adult rat. Biochem. Biophys. Res. Commun. 113:1983;127-134.
10. Cohen N.L., Keen C.L., Lonnerdal B., Hurley L.S., May J.N. Effects of varying dietary iron on the expression of copper deficiency in the growing rat: anaemia, ferroxidase I and II, tissue trace elements, ascorbic acid, and xanthine dehydrogenase. J. Nutr. 115:1985;633-649.
11. Dawson E.B., Albers J.H., McGanity W.J. The apparent effect of iron supplementation on serum selenium levels in teenage pregnancy. Biol. Trace Elem. Res. 77:2000;209-217.
12. de Cavanagh E.M., Ferder L., Carrasquedo F., Scrivo D., Wassermann A., Fraga C.G., Inserra F. Higher levels of antioxidant defences in enalapril-treated versus non-enalapril-treated hemodialysis patients. Am. J. Kidney Dis. 34:1999;445-455.
13. Ellervik C., Mandrup-Poulsen T., Nordestgaard B.G., Larsen L.E., Appleyard M., Frandsen M., Petersen P., Schlichting P., Saermark T., Tybjaerg-Hansen A., Birgens H. Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study. Lancet. 358:2001;1405-1409.
14. Fields M., Lewis C.G., Bureau I. Aspirin reduces blood cholesterol in copper-deficient rats: a potential antioxidant agent. Metabolism. 50:2001;558-561.
15. Galleano M., Puntarulo S. Dietary alpha-tocopherol supplementation on antioxidant defences after in vivo iron overload in rats. Toxicology. 124:1997;73-81.
16. Gavino V.C., Dillard C.J., Tappel A.L. Release of ethane and pentane from rat tissue slices: effect of vitamin E, halogenated hydrocarbons, and iron overload. Arch. Biochem. Biophys. 233:1984;741-747.
17. Girotti A.W., Thomas J.P., Jordan J.E. Inhibitory effect of Zn (II) on free radical lipid peroxidation in erythrocyte membranes. Free Radic. Biol. Med. 1:1985;395-401.
18. Gorelik S., Kanner J. Oxymyoglobin oxidation and membrane lipid peroxidation initiated by iron redox cycle: prevention of oxidation by enzymic and nonenzymic antioxidants. J. Agric. Food Chem. 49:2001;5945-5950.
19. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine. 1999;1-936 Oxford University Press, Oxford.
20. Har-El R., Chevion M. Zinc(II) protects against metal-mediated free radical induced damage: studies on single and double-strand DNA breakage. Free Radic. Res. Commun. 12:1991;509-515.
21. Herbert V., Shaw S., Jayatilleke E. Vitamin C-driven free radical generation from iron. J. Nutr. 126:1996;1213S-1220S.
22. Hollman P.C.H. Evidence for health benefits of plant phenols: local or systemic effects. J. Sci. Food Agric. 81:2001;842-852.
23. Hurrell R.F., Reddy M., Cook J.D. Inhibition of non-haem iron absorption in man by polyphenolic-containing beverages. Br. J. Nutr. 81:1999;289-295.
24. Kicic A., Chua A.C., Baker E. Effect of iron chelators on proliferation and iron uptake in hepatoma cells. Cancer. 92:2001;3093-3110.
25. Kostyuk V.A., Potapovich A.I., Vladykovskaya E.N., Korkina L.G., Afanas'ev I.B. Influence of metal ions on flavonoid protection against asbestos-induced cell injury. Arch. Biochem. Biophys. 385:2001;129-137.
26. Kris-Etherton P., Keen C.L. Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr. Opin. Lipidol. 13:2002;41-49.
27. Lachili B., Hininger I., Faure H., Arnaud J., Richard M.J., Favier A., Roussel A.M. Increased lipid peroxidation in pregnant women after iron and vitamin C supplementation. Biol. Trace Elem. Res. 83:2001;103-110.
28. Li J., Zhu Y., Singal D.P. HFE gene mutations in patients with rheumatoid arthritis. J. Rheumatol. 27:2000;2074-2077.
29. Lotito S.B., Actis-Goretta L., Renart L., Caligiuri M., Rein D., Schmitz H.H., Steinberg F.M., Keen C.L., Fraga C.G. Influence of oligomer chain length on the antioxidant activity of procyanidins. Biochem. Biophys. Res. Commun. 276:2000;945-951.
30. Lucesoli F., Fraga C.G. Oxidative damage to lipids and DNA concurrent with decrease of antioxidants in rat testes after acute iron intoxication. Arch. Biochem. Biophys. 316:1995;567-571.
31. Lucesoli F., Fraga C.G. Oxidative stress in testes of rats subjected to chronic iron intoxication and alpha-tocopherol supplementation. Toxicology. 132:1999;179-186.
32. Lucesoli F., Caligiuri M., Roberti M.F., Perazzo J.C., Fraga C.G. Dose-dependent increase of oxidative damage in the testes of rats subjected to acute iron overload. Arch. Biochem. Biophys. 372:1999;37-43.
33. Madra S., Mann F., Francis J.E., Manson M.M., Smith A.G. Modulation by iron of hepatic microsomal and nuclear cytochrome P450, and cytosolic glutathione S-transferase and peroxidase in C57BL/10ScSn mice induced with polychlorinated biphenyls (Aroclor 1254). Toxicol. Appl. Pharmacol. 136:1996;79-86.
34. Meister A. Glutathione metabolism. Methods Enzymol. 251:1995;3-7.
35. Merker H.J., Vormann J., Gunther T. Iron-induced injury of rat testis. Andrologia. 28:1996;267-273.
36. Milchak L.M., Douglas Bricker J. The effects of glutathione and vitamin E on iron toxicity in isolated rat hepatocytes. Toxicol. Lett. 126:2002;169-177.
37. Milman N., Pedersen P., Steig T., Byg K.E., Graudal N., Fenger K. Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients. Ann. Hematol. 80:2001;737-744.
38. Miyajima H., Nishimura Y., Mizoguchi K., Sakamoto M., Shimizu T., Honda N. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology. 37:1987;761-767.
39. Moran J.F., Klucas R.V., Grayer R.J., Abian J., Becana M. Complexes of iron with phenolic compounds from soybean nodules and other legume tissues: prooxidant and antioxidant properties. Free Radic. Biol. Med. 22:1997;861-870.
40. Morel I., Lescoat G., Cogrel P., Sergent O., Pasdeloup N., Brissot P., Cillard P., Cillard J. Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. Biochem. Pharmacol. 45:1993;13-19.
41. Oteiza P.I., Kleinman C.G., Demasi M., Bechara E.J. 5-Aminolevulinic acid induces iron release from ferritin. Arch. Biochem. Biophys. 316:1995a;607-611.
42. Oteiza P.I., Olin K.L., Fraga C.G., Keen C.L. Zinc deficiency causes oxidative damage to proteins, lipids and DNA in rat testes. J. Nutr. 125:1995b;823-829.
43. Oteiza P.L., Olin K.L., Fraga C.G., Keen C.L. Oxidant defence systems in testes from zinc-deficient rats. Proc. Soc. Exp. Biol. Med. 213:1996;85-91.
44. Oteiza P.I., Adonaylo V.N., Keen C.L. Cadmium-induced testes oxidative damage in rats can be influenced by dietary zinc intake. Toxicology. 137:1999;13-22.
45. Packer L., Cadenas E. Handbook of Synthetic Antioxidants. 1997;1-442 Marcel-Dekker, New York.
46. Packer L., Weber S.U., Rimbach G. Molecular aspects of alpha-tocotrienol antioxidant action and cell signalling. J. Nutr. 131:2001;369S-373S.
47. Parkkila S., Niemela O., Savolainen E.R., Koistinen P. HFE mutations do not account for transfusional iron overload in patients with acute myeloid leukemia. Transfusion. 41:2001;828-831.
48. Perez de Nanclares G., Castano L., Gaztambide S., Bilbao J.R., Pi J., Gonzalez M.L., Vazquez J.A. Excess iron storage in patients with type 2 diabetes unrelated to primary hemochromatosis. New Engl. J. Med. 343:2000;890-891.
49. Pietrangelo A., Borella F., Casalgrandi G., Montosi G., Ceccarelli D., Gallesi D., Giovannini F., Gasparetto A., Masini A. Antioxidant activity of silybin in vivo during long-term iron overload in rats. Gastroenterology. 109:1995;1941-1949.
50. Proteggente A.R., Rehman A., Halliwell B., Rice-Evans C.A. Potential problems of ascorbate and iron supplementation: pro-oxidant effect in vivo. Biochem. Biophys. Res. Commun. 227:2000;535-540.
51. Proteggente A.R., England T.G., Rice-Evans C.A., Halliwell B. Iron supplementation and oxidative damage to DNA in healthy individuals with high plasma ascorbate. Biochem. Biophys. Res. Commun. 288:2001;245-251.
52. Rasmussen M., Folsom A.R., Catellier D.J., Tsai M.Y., Garg U., Eckfeldt J.H. A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the atherosclerosis risk in communities (ARIC) study. Atherosclerosis. 154:2001;739-746.
53. Record I.R., McInerney J.K., Dreosti I.E. Black tea, green tea, and tea polyphenols. Effects on trace element status in weanling rats. Biol. Trace Elem. Res. 53:1996;27-43.
54. Ricciarelli R., Zingg J.M., Azzi A. Vitamin E: protective role of a Janus molecule. FASEB J. 15:2001;2314-2325.
55. Rogers J.M., Keen C.L., Hurley L.S. Zinc deficiency in pregnant Long-Evans hooded rats: teratogenicity and tissue trace elements. Teratology. 31:1985;89-100.
56. Rogers J.M., Lonnerdal B., Hurley L.S., Keen C.L. Iron and zinc concentrations and 59Fe retention in developing foetuses of zinc-deficient rats. J. Nutr. 117:1987;1875-1882.
57. Roob J.M., Khoschsorur G., Tiran A., Horina J.H., Holzer H., Winklhofer-Roob B.M. Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis. J. Am. Soc. Nephrol. 11:2000;539-549.
58. Salahudeen A.K., Oliver B., Bower J.D., Roberts L.J. Increase in plasma esterified F2-isoprostanes following intravenous iron infusion in patients on hemodialysis. Kidney Int. 60:2001;1525-1531.
59. Sayre L.M., Perry G., Atwood C.S., Smith M.A. The role of metals in neurodegenerative diseases. Cell. Mol. Biol. (Noisy-le-grand). 46:2000;731-741.
60. Sestili P., Guidarelli A., Dacha M., Cantoni O. Quercetin prevents DNA single strand breakage and cytotoxicity caused by tert-butylhydroperoxide: free radical scavenging versus iron chelating mechanism. Free Radic. Biol. Med. 25:1998;196-200.
61. Shirai M., Moon J.H., Tsushida T., Terao J. Inhibitory effect of a quercetin metabolite, quercetin 3-O-beta-D-glucuronide, on lipid peroxidation in liposomal membranes. J. Agric. Food Chem. 49:2001;5602-5608.
62. Stadtman E.R. Protein oxidation and ageing. Science. 257:1992;1220-1224.
63. Stadtman E.R., Levine R.L. Protein oxidation. Ann. New York Acad. Sci. 899:2000;191-208.
64. Tappel A.L., Dillard C.J. In vivo lipid peroxidation: measurement via exhaled pentane and protection by vitamin E. Fed. Proc. 40:1981;174-178.
65. Tenenbein M. Hepatotoxicity in acute iron poisoning. J. Toxicol. Clin. Toxicol. 39:2001;721-726.
66. van Acker S.A., van Balen G.P., van den Berg D.J., Bast A., van der Vijgh W.J. Influence of iron chelation on the antioxidant activity of flavonoids. Biochem. Pharmacol. 56:1998;935-943.
67. Verstraeten S.V., Oteiza P.I. Effects of Al(3+) and related metals on membrane phase state and hydration: correlation with lipid oxidation. Arch. Biochem. Biophys. 375:2000;340-346.
68. Verstraeten S.V., Nogueira L.V., Schreier S., Oteiza P.I. Effect of trivalent metal ions on phase separation and membrane lipid packing: role in lipid peroxidation. Arch. Biochem. Biophys. 338:1997;121-127.
69. 3+-mediated lipid oxidation: effect of galactolipids. Biochem. J. 333:1998;833-838.
70. Walker E.M.J., Walker S.M. Effects of iron overload on the immune system. Ann. Clin. Lab. Sci. 30:2000;354-365.
71. Wilkinson H. Haemochromatosis associated with arthritis and hypopituitarism. Ann. Clin. Biochem. 333:1996;171-173.
72. Yang Q., McDonnell S.M., Khoury M.J., Cono J., Parrish R.G. Hemochromatosis-associated mortality in the United States from 1979 to 1992: an analysis of Multiple-Cause Mortality Data. Ann. Intern. Med. 129:1998;946-953.
73. Yiin S.J., Chern C.L., Sheu J.Y., Lin T.H. Cadmium indiced lipid peroxidation in rat testes and protection by selenium. Biometals. 12:1999;353-359.
74. Zago M.P., Oteiza P.I. The antioxidant properties of zinc: interactions with iron and antioxidants. Free Radic. Biol. Med. 31:2001;266-274.
75. 2+-initiated lipid and protein oxidation. Biol. Res. 33:2000;143-150.